Geographic atrophy due to age-related macular degeneration (AMD) is the leading cause of irreversible blindness and affects more than 5 million persons worldwide. No therapies to restore vision in ...

Researchers successfully tested the safety and preliminary efficacy of stem-cell-derived corneal implants, showing promise for restoring vision in patients with severe corneal damage.

All the science news you can handle in a single feed

A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new future for vision restoration. A wireless retinal implant has been shown to restore...

YouTube video by Science Featured

At UC San Diego’s Qualcomm Institute and Jacobs School of Engineering, Shadi Dayeh leads bold research from brain-computer interfaces to pioneering optic nerve transplants.

YouTube video by Tetragrammaton with Rick Rubin

Blocking the PROX1 protein allowed KAIST researchers to regenerate damaged retinas and restore vision in mice. Vision is one of the most important human senses, yet more than 300 million people around...

From Turin comes a surgical world-first: the simultaneous transplant of a complete human macula, along with the cornea, sclera, and connective tissue, from one of the patient’s eyes to the other. It allowed a woman blind for several years to immediately gain enough vision to recognize both her son and her faithful canine companion, Joe. […] The post Woman Can See Again After World’s First Transplant of a Central Retina appeared first on Good News Network.

A team of researchers has developed experimental eye drops containing photoswitchable small molecules that restore saccadic eye movements and visually guided behaviors in blind mice. This breakthrough, led by scientists at the Institute for Bioengineering of Catalonia (IBEC), could pave the way for treating advanced retinal degeneration in humans. The study demonstrates that these molecules can activate light-sensitive proteins in damaged retinas, enabling photoreceptor cells to respond to ambient light even when traditional vision is lost. This approach is notable for its potential universality, as it works independently of specific genetic mutations or retinal disorders, making it applicable to a wide range of patients. The research was funded by multiple organizations including Fundaluce, CaixaHealth, and the Government of Catalonia, with significant contributions from Rosalba Sortino's doctoral thesis at the University of Barcelona. If successful in human trials, this technology could offer an affordable and accessible alternative to existing vision-restoration methods, particularly for individuals with advanced retinal degeneration who currently lack effective treatments. The findings were published in the Journal of the American Chemical Society and highlight the promising future of gene therapy and molecular engineering in ophthalmology.